The active metabolite of spleen tyrosine kinase inhibitor fostamatinib abrogates the CD4⁺ T cell-priming capacity of dendritic cells

Andrew M Platt, Robert A Benson, Ross McQueenie, John P Butcher, Martin Braddock, James M Brewer, Iain B McInnes, Paul Garside

Research output: Contribution to journal › Article › peer-review

13 Citations (Scopus)

Fingerprint

Dive into the research topics of 'The active metabolite of spleen tyrosine kinase inhibitor fostamatinib abrogates the CD4⁺ T cell-priming capacity of dendritic cells'. Together they form a unique fingerprint.

Keyphrases

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science